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Letters
RESEARCH LETTER
Medical End-of-Life Practices in Switzerland:
A Comparison of 2001 and 2013
Physician-assisted suicide, but not euthanasia, is legal in
Switzerland.1 The Netherlands and Belgium, where euthana-
sia is legal, regularlymonitor the incidence ofmedical end-of-
life practices.2,3 As part of a
study in 6 European coun-
tries, reliable data onmedical
end-of-lifepracticeswerecol-
lected in theGerman-speakingpartof Switzerland in2001.4To
assess trends in physician-assisted suicide and other medical
end-of-life practices,we conducted an identical study in Swit-
zerland in 2013.
Methods | A detailed description of the methods used in our
study has been published elsewhere.2,4 On the basis of a ran-
domsample of death certificates in theGerman-speakingpart
of Switzerland (containing 70% of the country’s total 8.1 mil-
lion residents and themajor cities of Zurich, Basel, and Bern)
filed betweenAugust 2013 and January 2014,wemailed4998
questionnaires to the decedents’ attending physicians under
conditions of strict anonymity, ofwhich 3173 (63.5%)were re-
turned. All data from 2001 and 2013 were weighted to adjust
for age- and sex-relateddifferences in response rates andwere
age-standardized to the age distribution of Swiss residents at
death in 2013. Two-sidedP values for the comparison of 2001
and 2013 data were calculated using the Pearson χ2 test for
2-way contingency tables (STATA survey tables for weighted
data; STATACorp LP).
Results | In2013, a total of 71.4%ofall deaths inour studypopu-
lation fromtheGerman-speakingpartofSwitzerlandwerenon-
suddenandexpected and therefore eligible for end-of-life de-
cisions. In 58.7% of all sampled deaths, at least 1 end-of-life
decisionwasmade, comparedwith a corresponding 52.0% in
2001 (P < .001) (Table).
Viewpoint
Table. Frequency ofMedical End-of-Life Practices in the German-Speaking Part of Switzerland, 2001 and 2013
Characteristic
Valuesa
P Value2001b 2013
Sampled cases, No. 4991 4998
Studied cases (response rate), No. (%) 3355 (67.2) 3173 (63.5)
Nonsudden, expected deaths 69.9 (68.3-71.4) 71.4 (69.8-72.9) .19
Deaths preceded by at least 1 end-of-life practicec 52.0 (50.3-53.8) 58.7 (57.0-60.4) <.001
Forgoing life-prolonging treatmentd 28.7 (27.2-30.4) 35.2 (33.6-36.9) <.001
Intensified alleviation of symptomse 22.3 (20.9-23.8) 21.3 (19.9-22.7) .31
Physician-assisted death 1.0 (0.7-1.4) 2.2 (1.8-2.8) <.001
Assisted suicidef 0.3 (0.2-0.5) 1.1 (0.8-1.5) <.001
Euthanasiag 0.2 (0.1-0.5) 0.3 (0.2-0.6) .41
Ending of life without the patient’s explicit requesth 0.5 (0.3-0.8) 0.8 (0.5-1.2) .08
Continuous deep sedation until deathi 4.7 (4.0-5.4) 17.5 (16.2-18.8) <.001
Without end-of-life decision 0.9 (0.6-1.3) 1.2 (0.9-1.6) .26
Combined with
Forgoing life-prolonging treatment 2.0 (1.6-2.6) 10.9 (9.8-12.0) <.001
Intensified alleviation of symptoms 1.6 (1.2-2.1) 4.9 (4.1-5.7) <.001
Physician-assisted death 0.1 (0.1-0.3) 0.5 (0.3-0.9) .005
a Data are presented as percentage (95% CI) unless otherwise noted.
bData for 2001 are age standardized to 2013. This may entail slight differences
to previously published figures.
c All data regarding these practices are weighted percentages (95% CIs) of all
studied cases.
dAffirmative answer to the question, “Did you or another physician withhold or
withdraw amedical treatment while taking into account the possible
hastening of death?”
e Affirmative answer to the question, “Did you or another physician intensify the
alleviation of pain and/or symptoms while taking into account the possible
hastening of death?”
f Affirmative answer to the question, “Was death the consequence of the use of
a drug that was prescribed or supplied by you or another physician with the
explicit intention of enabling the patient to end his or her life?”
g Affirmative answer to the question, “Was death the consequence of the use of
a drug that was administered by you or another physician with the explicit
intention of hastening the patient’s death?” AND affirmative answer to the
question, “Was this decisionmade at the explicit request of the patient?”
h Affirmative answer to the question, “Was death the consequence of the use of
a drug that was administered by you or another physician with the explicit
intention of hastening the patient’s death?” AND negative answer to the
question, “Was this decisionmade at the explicit request of the patient?”
i Affirmative answer to the question, “Did the patient receive drugs, such as
benzodiazepines and/or other sedative substances, to keep him or her in deep
sedation or coma until death?”
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The percentage of deaths in which life-prolonging treat-
ment was forgone increased from 28.7% of all deaths in 2001
to 35.2% of all deaths in 2013 (P < .001). The percentage of
deaths thatwereprecededby intensifiedalleviationofpainand
symptoms remained stable (22.3% in 2001 vs 21.3% in 2013).
Physician-assisted death increased from 1.0% in 2001 to
2.2% in2013 (P < .001),with assisted suicide increasing in the
sameperiod from0.3%to 1.1% (P < .001). Euthanasia andend-
ing of life without the patient’s explicit request also in-
creased, but the number of studied cases of the 2 categories
was small, at 8 and 15 cases in 2001, and at 11 and 25 cases in
2013, respectively, and the increases, from 0.2% to 0.3% for
euthanasia and from 0.5% to 0.8% for ending of life without
the patient’s explicit request, were not significant.
The greatest increase was in the use of continuous deep
sedationuntildeath,which rose from4.7%ofalldeaths in2001
to 17.5% in 2013 (P < .001). Sedation was combined with for-
going life-prolonging treatment, alleviationof pain and symp-
toms,orphysician-assisteddeath in62%,28%,and3%ofcases,
respectively.
Discussion | In Switzerland in 2013, more than 4 of 5 non-
sudden deaths, corresponding to 58.7% of all deaths, were
precededbyat least 1 specific end-of-life practice in2013 com-
pared with 52.0% in 2001. Similar increases in medical end-
of-life practiceswere reported in theNetherlands, from43.8%
in 2001 to 57.8% in 2010, and in Belgium, from38.4% in 2001
to 47.8% in 2013.2,3
Forgoing life-prolonging treatmentand intensifiedallevia-
tionofpainandsymptomsconstitute thevastmajorityofmedi-
cal end-of-life practices. In Switzerland, an increase in theper-
centage of deaths in which life-prolonging treatment was
forgonepredominatedamongmedicalend-of-lifepractices.This
trendcontrastswiththesituation intheNetherlands,where for-
going life-prolonging treatmentdecreasedslightly, from20.2%
in 2001 to 18.2% in 2010, and intensified alleviation of symp-
toms increased from 20.1% in 2001 to 36.4% in 2010.2
In Switzerland, physician-assisted death occurs mainly
as assisted suicide. We were unable to establish how many
such deaths involved foreigners without permanent resi-
dence in Switzerland.5 The trends in euthanasia and ending
of life without the patient’s explicit request, both of which
are illegal in Switzerland, reflected small absolute differ-
ences in numbers for these 2 practices from 2001 to 2013
and are difficult to interpret.
In our study population, the substantial increase in the
use of continuous deep sedation until death, from 4.7% of all
deaths in 2001 to 17.5% in 2013, is noteworthy; this practice
was therefore more common in Switzerland than in either
Belgium (12.0% in 2013) or the Netherlands (12.3% in
2010).2,3 In 2005, the Swiss Association of Palliative Care
released specific guidelines on palliative sedation.6 These
guidelines may have stimulated both awareness of palliative
sedation and the practice itself.
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